<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-12-24 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-12-24/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-12-24"><meta property="og:description" content="ğŸ“… Daily Report - 2025-12-24 ä»Šæ—¥ç­›é€‰å‡º 64 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-12-24T00:00:00+00:00"><meta property="article:modified_time" content="2025-12-24T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week522025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-12-24"><meta itemprop=description content="ğŸ“… Daily Report - 2025-12-24 ä»Šæ—¥ç­›é€‰å‡º 64 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-12-24T00:00:00+00:00"><meta itemprop=dateModified content="2025-12-24T00:00:00+00:00"><meta itemprop=wordCount content="2614"><meta itemprop=keywords content="Research,Daily,Week522025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-12-24"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-12-24 ä»Šæ—¥ç­›é€‰å‡º 64 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-24</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-12-24T00:00:00Z>2025-12-24</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-12-24>ğŸ“… Daily Report - 2025-12-24</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>64</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
Combined epigenetic therapy with FACT and BET inhibitors remodels chromatin and disrupts oncogenic transcription in Diffuse Midline Glioma.</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç¥ç»é€€è¡Œæ€§ç–¾ç—…</strong>ï¼šæ¢ç´¢ALSæ‚£è€…è¯­è¨€åŠæ‰§è¡ŒåŠŸèƒ½ä¸‹é™çš„ç»†èƒæœºåˆ¶ï¼ˆVisiumç©ºé—´è½¬å½•ç»„å­¦ï¼‰ã€‚</li><li><strong>è„‘è¡°è€æœºåˆ¶</strong>ï¼šè§£æå¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ å­¦ç‰¹å¾ï¼ˆå•æ ¸ç”²åŸºåŒ–æµ‹åºï¼‰ã€‚</li><li><strong>è‚¿ç˜¤æ²»ç–—</strong>ï¼šç ”ç©¶NSD2é¶å‘æ²»ç–—å¯¹å‰åˆ—è…ºç™Œè€è¯æ€§çš„é€†è½¬ï¼ˆRNA-seq, Cut&amp;Tag, snATAC-seq, multiomeï¼‰ã€‚</li><li><strong>å„¿ç§‘è„‘è‚¿ç˜¤</strong>ï¼šè¯„ä¼°è”åˆè¡¨è§‚é—ä¼ ç–—æ³•å¯¹å¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤çš„ç–—æ•ˆï¼ˆRNA-seq, ATAC-seq, Xenium, CUT&amp;RUNï¼‰ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆå•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦ã€å•æ ¸ç”²åŸºåŒ–æµ‹åºã€å¤šç»„å­¦åˆ†æç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æå¤æ‚ç”Ÿç‰©å­¦è¿‡ç¨‹ã€‚</li><li><strong>æ–°å‹ç–—æ³•è¯„ä¼°</strong>ï¼šåˆ©ç”¨å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼ˆå¦‚Visium, Xenium, Nascent RNA-Seq, CUT&amp;RUNï¼‰è¯„ä¼°è”åˆè¡¨è§‚é—ä¼ ç–—æ³•çš„æ•ˆæœã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ä¸€é¡¹æ–°å‹è¯ç‰©NU-9æœ‰æœ›åœ¨é˜¿å°”èŒ¨æµ·é»˜ç—…æ—©æœŸï¼ˆè®°å¿†ä¸§å¤±å‰ï¼‰é˜»æ–­ç–¾ç—…è¿›å±•ï¼›ç§‘å­¦å®¶é¦–æ¬¡åœ¨å®éªŒå®¤æˆåŠŸåˆæˆäº†å…·æœ‰å¤æ‚ç»“æ„çš„æŠ—ç™Œåˆ†å­verticillin Aã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>é˜¿å°”èŒ¨æµ·é»˜ç—…æ—©æœŸæœºåˆ¶ä¸å¹²é¢„</li><li>å¤æ‚å¤©ç„¶äº§ç‰©çš„å…¨åˆæˆä¸åº”ç”¨</li><li>å•ç»†èƒRNAæµ‹åºæŠ€æœ¯åœ¨åŸºå› è°ƒæ§ç ”ç©¶ä¸­çš„åº”ç”¨</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ASPENæ–¹æ³•å¢å¼ºå•ç»†èƒRNAæµ‹åºä¸­ç­‰ä½åŸºå› åŠ¨åŠ›å­¦æ£€æµ‹èƒ½åŠ›ã€‚</li><li>CRISPRiç­›é€‰ä¸RNAæµ‹åºç»“åˆï¼Œæ­ç¤ºä¸é˜¿å°”èŒ¨æµ·é»˜ç—…ç›¸å…³çš„åŸºå› è°ƒæ§ç½‘ç»œã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (60æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE313918 è‚Œèç¼©ä¾§ç´¢ç¡¬åŒ–ç—‡ä¸­è¯­è¨€å’Œæ‰§è¡ŒåŠŸèƒ½è¡°é€€çš„å·®å¼‚æ€§ç»†èƒæœºåˆ¶ [Visium ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€Visiumã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : C Jackson ; A Daly ; C Roque ; J Petrescu ; H PhatnaniSeries Type : OtherOrganism : Homo sapiensHalf of all amyotrophic lateral sclerosis (ALS) patients demonstrate a spectrum of cognitive and behavioral changes over the course of the disease, but the mechanisms underlying this heterogeneity remain unclear. We assemble a high-resolution cellular map of prefrontal cortex regions of the ALS brain by integrating spatial and single-nucleus transcriptomic profiles of a cognitively stratified ALS patient cohort that includes non-neuropathological controls. We find cellular programs characteristic of ALS, including a frequent gliotic response. We also find that executive and language cognitive impairments differ from ALS without cognitive impairment, and from each other, in the extent and pattern of neuronal dysregulation and neuron-glial interactions across different brain regions. These findings reveal a relationship between cognitive phenotype and prefrontal cortex dysfunction in ALS.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313918">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE169273 é€šè¿‡å•æ ¸ç”²åŸºåŒ–æµ‹åºç ”ç©¶å¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ ç‰¹å¾ [DHC-18mo-m-002]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€sequencingã€epigeneticã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wei Tian ; Anna Bartlett ; Jordan Altshul ; Rosa Gomez Castanon ; Joseph R Nery ; Jacinta D Lucero ; Julia K Osteen ; Huaming Chen ; M M Behrens ; Joseph R EckerSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusIllustrating aging effects on the epigenomic features of brain is critical to understand brain functional decline and neurodegeneration. Single nucleus methylation sequencing was applied to brain regions of mouse at the age of 2, 9 and 18 months. We use these data to identify the epigenomic changes with aging in mouse brains.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169273">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE299509 è¡¨è§‚é—ä¼ ç–—æ³•è”åˆ FACT å’Œ BET æŠ‘åˆ¶å‰‚å¯é‡å¡‘æŸ“è‰²è´¨å¹¶ç ´åå¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤ä¸­çš„è‡´ç™Œè½¬å½• [æ–°ç”Ÿ RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgliomaã€regex:onco(logy|logist|gene|genic)ã€RNA-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Holly Holliday ; Chelsea MayohSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAberrant epigenetic regulation is a hallmark of Diffuse Midline Glioma (DMG), an incurable pediatric brain tumor. The H3K27M driver histone mutation leads to transcriptional dysregulation, indicating that targeting the epigenome and transcription may be key therapeutic strategies against this highly aggressive cancer. One such target is the Facilitates Chromatin Transcription (FACT) histone chaperone. We found FACT to be enriched at developmental gene promoters, coinciding with regions of open chromatin and binding motifs of core DMG regulatory transcription factors. Furthermore, FACT interacted and co-localized with the Bromodomain and Extra-Terminal Domain (BET) protein BRD4 at promoters and enhancers, suggesting functional cooperation between FACT and BRD4 in DMG. In vitro, a combinatorial therapeutic approach using the FACT inhibitor CBL0137, coupled with BET inhibition revealed potent and synergistic cytotoxicity across a range of DMG cultures. These results were recapitulated in vivo, significantly extending survival in three independent orthotopic PDX models of DMG. Mechanistically, we show that CBL0137 treatment decreased chromatin accessibility, synergizing with BET inhibition to cause broad transcriptional collapse, silencing several key oncogenes including MYC, PDGFRA, MDM4 and SOX2, as well as causing alterations to the splicing landscape. Notably, this combination also elicited immune-related effects, including activation of the interferon response and antigen presentation mechanisms in DMG cells and induction of an activated state in macrophages and T cells, as demonstrated in an immunocompetent setting with spatial transcriptomics. Altogether, our data highlights the therapeutic promise of simultaneously targeting FACT and BET proteins in DMG, offering a dual tumor-intrinsic and immune-mediated strategy for combating this devastating pediatric brain tumor.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299509">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE272131 è¡¨è§‚é—ä¼ ç–—æ³•è”åˆ FACT å’Œ BET æŠ‘åˆ¶å‰‚å¯é‡å¡‘æŸ“è‰²è´¨å¹¶ç ´åå¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤ä¸­çš„è‡´ç™Œè½¬å½• [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgliomaã€regex:onco(logy|logist|gene|genic)ã€RNA-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Holly Holliday ; Nisitha Jayatilleke ; Chelsea Mayoh ; Xinyi GuoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAberrant epigenetic regulation is a hallmark of Diffuse Midline Glioma (DMG), an incurable pediatric brain tumor. The H3K27M driver histone mutation leads to transcriptional dysregulation, indicating that targeting the epigenome and transcription may be a key therapeutic strategy against this highly aggressive cancer. One such target is the Facilitates Chromatin Transcription (FACT) histone chaperone. We found FACT to be enriched at developmental gene promoters, coinciding with regions of open chromatin and binding motifs of core DMG regulatory transcription factors. Furthermore, FACT interacted and co-localized with the Bromodomain and Extra-Terminal Domain (BET) protein BRD4 at promoters and enhancers, suggesting functional cooperation between FACT and BRD4 in DMG. In vitro, a combinatorial therapeutic approach using the FACT inhibitor CBL0137, coupled with BET inhibition revealed potent and synergistic cytotoxicity across a range of DMG cultures, with H3K27M-mutant cells demonstrating heightened sensitivity. These results were recapitulated in vivo, significantly extending survival in three independent orthotopic PDX models of DMG. Mechanistically, we show that CBL0137 treatment decreased chromatin accessibility, synergizing with BET inhibition to disrupt transcription, silencing several key oncogenes including MYC, PDGFRA and MDM4, alongside alterations to the splicing landscape. Combined, these data highlight the therapeutic promise of simultaneously targeting FACT and BRD4 in DMG, proposing a novel strategy for combating this devastating pediatric brain tumor.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272131">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE272129 è¡¨è§‚é—ä¼ ç–—æ³•è”åˆ FACT å’Œ BET æŠ‘åˆ¶å‰‚å¯é‡å¡‘æŸ“è‰²è´¨å¹¶ç ´åå¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤ä¸­çš„è‡´ç™Œè½¬å½• [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgliomaã€regex:onco(logy|logist|gene|genic)ã€ATAC-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Holly Holliday ; Nisitha Jayatilleke ; Chelsea Mayoh ; Samuel E RossSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensAberrant epigenetic regulation is a hallmark of Diffuse Midline Glioma (DMG), an incurable pediatric brain tumor. The H3K27M driver histone mutation leads to transcriptional dysregulation, indicating that targeting the epigenome and transcription may be a key therapeutic strategy against this highly aggressive cancer. One such target is the Facilitates Chromatin Transcription (FACT) histone chaperone. We found FACT to be enriched at developmental gene promoters, coinciding with regions of open chromatin and binding motifs of core DMG regulatory transcription factors. Furthermore, FACT interacted and co-localized with the Bromodomain and Extra-Terminal Domain (BET) protein BRD4 at promoters and enhancers, suggesting functional cooperation between FACT and BRD4 in DMG. In vitro, a combinatorial therapeutic approach using the FACT inhibitor CBL0137, coupled with BET inhibition revealed potent and synergistic cytotoxicity across a range of DMG cultures, with H3K27M-mutant cells demonstrating heightened sensitivity. These results were recapitulated in vivo, significantly extending survival in three independent orthotopic PDX models of DMG. Mechanistically, we show that CBL0137 treatment decreased chromatin accessibility, synergizing with BET inhibition to disrupt transcription, silencing several key oncogenes including MYC, PDGFRA and MDM4, alongside alterations to the splicing landscape. Combined, these data highlight the therapeutic promise of simultaneously targeting FACT and BRD4 in DMG, proposing a novel strategy for combating this devastating pediatric brain tumor.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272129">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE169345 é€šè¿‡å•æ ¸ç”²åŸºåŒ–æµ‹åºç ”ç©¶å¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ ç‰¹å¾ [DHC-18mo-m-003]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€sequencingã€epigeneticã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wei Tian ; Anna Bartlett ; Jordan Altshul ; Rosa Gomez Castanon ; Joseph R Nery ; Jacinta D Lucero ; Julia K Osteen ; Huaming Chen ; M M Behrens ; Joseph R EckerSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusIllustrating aging effects on the epigenomic features of brain is critical to understand brain functional decline and neurodegeneration. Single nucleus methylation sequencing was applied to brain regions of both male and female mouse at the age of 2, 9 and 18 months. We use these data to identify the epigenomic changes with aging in mouse brains.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169345">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE314260 äººç±»èº¯å¹²èƒšçŠ¶ä½“æ¨¡å‹ï¼ˆhTEMï¼‰çš„å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tianming Wu ; Hao Yu ; Brian Wong ; Ling Xu ; Joaquim Vong ; Stephen DaltonSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensHuman embryoid models enable mechanistic studies of development and disease. We generated trunk embryoids from human pluripotent stem cells that recapitulate posterior trunk formation at Carnegie stage (CS) 8-10, with patterned anterior-posterior (A-P) and dorsal-ventral (D-V) axes. These self-organizing structures comprise a ventral notochord, dorsal neural tube, floor plate and bilateral somites. Genetic and chemical perturbations of SHH signaling confirmed the notochordâ€™s central role in D-V patterning. Moreover, VANGL1/2 loss-of-function mutations recapitulated mouse phenotypes, including axial truncation and somite segmentation failure. This model enables detailed study of key developmental events that underlie posterior trunk formation and provides a promising platform for human disease modeling.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314260">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE314059 åˆ©ç”¨é•¿è¯»æµ‹åºæŠ€æœ¯å¯¹å°é¼ è„‘è¿›è¡Œå•ç»†èƒå’Œäºšå‹ç‰¹å¼‚æ€§ç¿»è¯‘åˆ†æ [scRNA-Seq, longread]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samantha L Sison ; Federico Zampa ; Eric R Kofman ; Su Yeun Choi ; Pratibha Jagannatha ; Gene W Yeo ; Giordano LippiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe brain displays the richest repertoire of post-transcriptional mechanisms regulating mRNA translation. Among these, alternative splicing has been shown to drive cell type specificity and, when disrupted, is strongly linked to neurological disorders. However, genome-wide measurements of mRNA translation with isoform-sensitivity at single-cell (sc) resolution have not been achieved. To address this, we deployed Ribo-STAMP (Surveying Ribosomal Targets by APOBEC-Mediated Profiling) coupled with long-read scRNA-sequencing (scRNA-seq) in the brain. We generated the first isoform-sensitive sc translatomes of the mouse hippocampus at postnatal day 25, discovering cell type-specific translation of 3,857 alternative transcripts across 1,641 genes, and identifying isoforms of the same genes undergoing differential translation within and across eight different cell types. We defined high and low translational states in CA1 and CA3 neurons, with synaptic and metabolic genes enriched in high states. Surprisingly, we found that CA3 exhibited higher basal translation compared to CA1, as confirmed by metabolic labeling of newly synthesized proteins and immunohistochemistry of translational machinery components. This accessible platform will expand our understanding of how cell type- and isoform-specific translation drives brain physiology and disease.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314059">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE308993 NSD2é¶å‘é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§[æ‰¹é‡RNAæµ‹åº]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jia J Li ; Kristjan H Gretarsson ; Michael M ShenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTreatment with highly potent androgen receptor signaling inhibitors (ARSIs), such as enzalutamide and abiraterone promotes lineage plasticity in metastatic castration-resistant prostate cancer (mCRPC), which results in intra-tumor heterogeneity and emergence of mCRPC subtypes. The histological transformation from adenocarcinoma to aggressive neuroendocrine prostate cancer (CRPC-NE) has been associated with a loss of dependency on lineage-survival signals, leading to targeted drug resistance. Epigenomic reprogramming might be a fundamental driver of lineage plasticity. To determine CRPC-NE vulnerabilities, we have performed image-based screening using a small library of antibodies targeting different histone marks on CRPC-NE organoids derived from genetically engineered mice. We find that the histone mark H3K36me2 and the histone methyltransferase NSD2 (also known as MMSET/WHSC1) play important roles in maintaining the state of CRPC-NE. Knockout of NSD2 or ablation of H3K36me2 using H3.3K36M oncohistone reverted CRPC-NE to CRPC-AR-like phenotype. Simultaneous profiling of the transcriptome and epigenome from single cells collected from control (sgCtrl) and NSD2 knockout (sgNSD2) organoids, or from empty vector (EV) and H3.3K36M transduced organoids confirms the lineage reversal of treatment-resistant cells and maps the re-establishment of canonical AR signaling dependency. Moreover, H3K36me2 or NSD2 depleted mouse and human CRPC-NE organoids responded to enzalutamide treatment in vitro and in vivo, suggesting a restoration of ARSI sensitivity. Most importantly, a small molecule inhibitor of NSD2, which is similar to KTX-1001 (NCT05651932), in combination with enzalutamide leads to growth suppression or apoptosis of mouse and human CRPC-NE organoids, organoids of other CRPC subtypes and xenografts in vitro and in vivo. In conclusion, inhibition of NSD2 reverses lineage plasticity and reverts the state of treatment-resistant cells back into an ARSI-sensitive state. Thus, we suggest that the combination of NSD2 inhibition with AR inhibition may represent a novel therapeutic approach for patients with CRPC-NE and other CRPC subtypes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308993">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE286020 SETD6 å¯¹ E2F1 çš„ç”²åŸºåŒ–ç ´åäº† BRD4-E2F1 çš„ç»“åˆï¼Œå¹¶è°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒä¸­çš„åŸºå› è°ƒæ§ [ChIP-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ChIP-seqã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Gizem T Ulu ; Margarita Kublanovsky ; Michal Feldman ; Sara Weirich ; Dan Levy ; Albert JeltschSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe SETD6 protein lysine methyltransferase has a role in the regulation of various cellular processes including cancer initiation and progression. It methylates several cellular proteins including K117 of the E2F1 transcription factor, but the functional consequences of this methylation event are unknown. In this study, the role of SETD6 mediated E2F1 methylation on the progression of prostate cancer was investigated. We identified distinct sets of genes that are bound and upregulated by methylated and unmethylated E2F1. Genes upregulated by methylated E2F1 lead to the negative regulation of cell migration, while genes upregulated by unmethylated E2F1 have roles in cell proliferation and apoptosis. BRD4 is known to bind E2F1 acetylated at K117 and K120. Here, we demonstrate that methylation of E2F1 at K117 prevents E2F1-BRD4 binding of in vitro and in cells establishing the molecular mechanism of the differential gene regulation by methylated and unmethylated E2F1 that depends on SETD6 activity.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286020">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 50 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨4æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ASPENâ€”â€”å•ç»†èƒRNAæµ‹åºä¸­ç­‰ä½åŸºå› åŠ¨æ€çš„ç¨³å¥æ£€æµ‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šNew ASPEN method enhances detection of allelic imbalance and variance in RNA sequencing data, revealing subtle gene regulation patterns in single cells&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/aspen-robust-detection-of-allelic-dynamics-in-single-cell-rna-seq/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>é˜¿å°”èŒ¨æµ·é»˜ç—…çš„çº¿ç´¢å¯èƒ½å°±éšè—åœ¨æˆ‘ä»¬çš„â€œåƒåœ¾â€DNAä¸­ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šCRISPRi screening with RNA sequencing maps functional DNA enhancers in human astrocytes, revealing gene control networks linked to Alzheimerâ€™s disease&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/clues-to-alzheimers-disease-may-be-hiding-in-our-junk-dna/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>ä¸€ç§æ–°è¯æœ‰æœ›åœ¨è®°å¿†ä¸§å¤±å¼€å§‹å‰é˜»æ­¢é˜¿å°”èŒ¨æµ·é»˜ç—…çš„å‘å±•ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šNew research suggests Alzheimerâ€™s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimerâ€™s is prevented and treated.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/12/251222080119.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>è¿™ç§æŠ—ç™Œåˆ†å­å†ç»50å¹´æ‰ç ”åˆ¶æˆåŠŸã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šMIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from related molecules by only two atoms. With the synthesis finally complete, researchers created new variants that showed strong activity against a rare pediatric brain cancer. The breakthrough could unlock an entire class of previously unreachable cancer-fighting molecules.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/12/251222044104.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>12</td></tr><tr><td>epigenetic</td><td>12</td></tr><tr><td>cancer</td><td>11</td></tr><tr><td>sequencing</td><td>8</td></tr><tr><td>single-cell</td><td>7</td></tr><tr><td>aging</td><td>7</td></tr><tr><td>resistance</td><td>6</td></tr><tr><td>tumor</td><td>6</td></tr><tr><td>glioma</td><td>5</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>scRNA</td><td>4</td></tr><tr><td>spatial</td><td>4</td></tr><tr><td>immune</td><td>4</td></tr><tr><td>methylation</td><td>4</td></tr><tr><td>Alzheimer</td><td>2</td></tr><tr><td>Visium</td><td>2</td></tr><tr><td>spatial transcriptomics</td><td>2</td></tr><tr><td>transcriptomics</td><td>2</td></tr><tr><td>ChIP-seq</td><td>2</td></tr><tr><td>metabolic</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (50æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237191">GSE237191 NSD2é¶å‘é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§[scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314805">GSE314805 å‰åˆ—è…ºè‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒåœ¨æ¥å—å…ç–«æ²»ç–—åå‘ç”Ÿå˜åŒ–ï¼Œè¿™äº›å˜åŒ–ç”±å‡ºç°æŠ—è‚¿ç˜¤ååº”æˆ–å…ç–«ç›¸å…³ä¸è‰¯äº‹ä»¶çš„æ‚£è€…åˆ†äº«</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299434">GSE299434 è¡¨è§‚é—ä¼ ç–—æ³•è”åˆ FACT å’Œ BET æŠ‘åˆ¶å‰‚å¯é‡å¡‘æŸ“è‰²è´¨å¹¶ç ´åå¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤ä¸­çš„è‡´ç™Œè½¬å½• [Xenium]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272130">GSE272130 è¡¨è§‚é—ä¼ ç–—æ³•è”åˆ FACT å’Œ BET æŠ‘åˆ¶å‰‚å¯é‡å¡‘æŸ“è‰²è´¨å¹¶ç ´åå¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤ä¸­çš„è‡´ç™Œè½¬å½• [CUT&amp;RUN]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313870">GSE313870 æ•´åˆç»„å­¦åˆ†æé˜æ˜äº† ANKRD9 é€šè¿‡å˜Œå‘¤ä»£è°¢é€”å¾„è°ƒæ§é¸¡åŸä»£æˆè‚Œç»†èƒ IMP ä»£è°¢çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314058">GSE314058 å°é¼ è„‘å•ç»†èƒå’Œäºšå‹ç‰¹å¼‚æ€§ç¿»è¯‘åˆ†æ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308575">GSE308575 NSD2é¶å‘é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§ [Cut&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292146">GSE292146 æ˜“äºæ“ä½œçš„å°é¼  TNBC æ¨¡å‹æ•æ‰åˆ°äº†å¼‚è´¨æ€§è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒä»¥åŠå¯¹ PD-L1 é˜»æ–­çš„é€‚åº”æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291126">GSE291126 æ˜“äºæ“ä½œçš„å°é¼  TNBC æ¨¡å‹æ•æ‰åˆ°äº†å¼‚è´¨æ€§è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒä»¥åŠå¯¹ PD-L1 é˜»æ–­çš„é€‚åº”æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290815">GSE290815 æ˜“äºæ“ä½œçš„å°é¼  TNBC æ¨¡å‹æ•æ‰äº†è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒçš„å¼‚è´¨æ€§ä»¥åŠå¯¹ PD-L1 é˜»æ–­çš„é€‚åº”æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286198">GSE286198 SETD6ä»‹å¯¼çš„E2F1ç”²åŸºåŒ–ç ´åBRD4-E2F1ç»“åˆå¹¶è°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒä¸­çš„åŸºå› è¡¨è¾¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281998">GSE281998 ç»†èƒå¤–åŸºè´¨è›‹ç™½1å¡‘é€ è‚¾è„çº¤ç»´åŒ–å¾®ç¯å¢ƒçš„ä»£è°¢å’Œç©ºé—´åŠ¨æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237197">GSE237197 NSD2é¶å‘æ²»ç–—é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237196">GSE237196 NSD2é¶å‘é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§[snATAC-seqå’Œå¤šç»„snATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237195">GSE237195 NSD2é¶å‘é€†è½¬æ™šæœŸå‰åˆ—è…ºç™Œçš„è°±ç³»å¯å¡‘æ€§å’Œè€è¯æ€§[å¤šç»„snRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314569">GSE314569 è‚ é“èŒç¾¤ç¼ºå¤±å¯¹å¦Šå¨ å°é¼ èƒç›˜-è„‘è½´çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306072">GSE306072 ç ”ç©¶è¯„ä¼°äº†ç”¨è¡¨è§‚é—ä¼ æŠ‘åˆ¶å‰‚æ²»ç–—çš„è‚¿ç˜¤ç»†èƒä»¥åŠåœè¯åè‚¿ç˜¤ç»†èƒçš„åŸºå› è¡¨è¾¾å˜åŒ–ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314020">GSE314020 æœ‰ä¸åˆ†è£‚ç»†èƒä¸­è½¬å½•ç»„çš„å…¨å±€ç¨³å®šæ€§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313694">GSE313694 è„‘è†œç˜¤çš„ç©ºé—´è½¬å½•ç»„åˆ†æï¼ˆVisiumï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305964">GSE305964 å¤§é¼ ç›†è…”ç¥ç»æŸä¼¤å¼•èµ·çš„ç¥ç»æºæ€§è†€èƒ±çš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296159">GSE296159 æ·±åº¦é¶å‘æµ‹åºæ­ç¤ºåŸå‘æ€§å’Œå¤å‘æ€§é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œä¹‹é—´çš„åŸºå› ç»„å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293642">GSE293642 æ—¥æœ¬è¡€å¸è™«ç”Ÿæ®–å‘è‚²è¿‡ç¨‹ä¸­çš„å•ç»†èƒRNAæµ‹åºè°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289108">GSE289108 ç‚ç—‡è„‘ä¸­ç¥ç»å…ƒå‘ç”Ÿ IFNÎ³ é©±åŠ¨çš„æŒç»­è¡¨è§‚é—ä¼ æ”¹å˜å’Œçªè§¦é‡å¡‘ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289107">GSE289107 ç‚ç—‡è„‘ä¸­ç¥ç»å…ƒå‘ç”Ÿ IFNÎ³ é©±åŠ¨çš„æŒç»­è¡¨è§‚é—ä¼ æ”¹å˜å’Œçªè§¦é‡å¡‘ [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288606">GSE288606 ç¥ç»å…ƒåœ¨ç‚ç—‡è„‘ä¸­ç»å† IFNÎ³ é©±åŠ¨çš„æŒç»­è¡¨è§‚é—ä¼ æ”¹å˜å’Œçªè§¦é‡å¡‘ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293260">GSE293260 æš´éœ²äºé¦™çƒŸçƒŸé›¾çš„æˆå¹´å°é¼ ç¾ä¸¸å•ç»†èƒåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280334">GSE280334 é‰´å®šå·¨å™¬ç»†èƒä¾èµ–æ€§Fcer1g+é—´å……è´¨ç»†èƒä¸ºä¼¤å£æ„ˆåˆè¿‡ç¨‹ä¸­ç˜¢ç—•å½¢æˆçš„å…³é”®è°ƒèŠ‚å› å­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275133">GSE275133 å°é¼ è„‘å•ç»†èƒå’Œäºšå‹ç‰¹å¼‚æ€§ç¿»è¯‘åˆ†æ [æ‰¹é‡ RNA æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270776">GSE270776 VHL åˆæˆè‡´æ­»æ€§ç­›é€‰æ­ç¤º CBF-Î² æ˜¯ STING çš„è´Ÿè°ƒæ§å› å­ï¼ˆRNA-Seqï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314162">GSE314162 æ‚äº¤æ•è· RNA-seq å®šä¹‰äº†ç«‹å…‹æ¬¡ä½“ä¸­åŸºå› è¡¨è¾¾çš„æ—¶é—´åºåˆ—</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297352">GSE297352 ç ”ç©¶å‘ç°ï¼Œå¯é€†æ€§ç»†èƒè¡°è€ä¸­ RNA åŠ å·¥ç¼ºé™·å’Œ ELOA ä»‹å¯¼çš„è½¬å½•å»¶ä¼¸è¡¨æ˜è¡°è€æ˜¯é€šè¿‡è½¬å½•å®ç°çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285193">GSE285193 èƒ°è…ºç™Œæ¥æºçš„ç»†èƒå¤–å›Šæ³¡å¯¹éª¨é«“æ¥æºå·¨å™¬ç»†èƒçš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284368">GSE284368 ä¿ç•™èƒšèƒã€èƒšå¤–å’Œèƒšæ³¡ç”Ÿæˆæ½œèƒ½çš„åŸå§‹äººç±»å¤šèƒ½å¹²ç»†èƒçš„æ— é¥²å…»å±‚åŸ¹å…» [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269948">GSE269948 ç ”ç©¶å‘ç°ï¼Œå¯é€†æ€§ç»†èƒè¡°è€ä¸­ RNA åŠ å·¥ç¼ºé™·å’Œ ELOA ä»‹å¯¼çš„è½¬å½•å»¶ä¼¸è¡¨æ˜è¡°è€æ˜¯é€šè¿‡è½¬å½•å®ç°çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269718">GSE269718 ç ”ç©¶å‘ç°ï¼Œå¯é€†æ€§ç»†èƒè¡°è€ä¸­ RNA åŠ å·¥ç¼ºé™·å’Œ ELOA ä»‹å¯¼çš„è½¬å½•å»¶ä¼¸è¡¨æ˜è¡°è€æ˜¯é€šè¿‡è½¬å½•å®ç°çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269717">GSE269717 ç ”ç©¶å‘ç°ï¼Œå¯é€†æ€§ç»†èƒè¡°è€ä¸­ RNA åŠ å·¥ç¼ºé™·å’Œ ELOA ä»‹å¯¼çš„è½¬å½•å»¶ä¼¸æç¤ºè¡°è€æ˜¯é€šè¿‡è½¬å½•å®ç°çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269715">GSE269715 ç ”ç©¶å‘ç°ï¼Œå¯é€†æ€§ç»†èƒè¡°è€ä¸­ RNA åŠ å·¥ç¼ºé™·å’Œ ELOA ä»‹å¯¼çš„è½¬å½•å»¶ä¼¸æç¤ºè¡°è€æ˜¯é€šè¿‡è½¬å½•å®ç°çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311598">GSE311598 æˆç†Ÿè„‚è‚ªç»†èƒä¸­èŠ³çƒƒå—ä½“çš„æ¿€æ´»ä¸å½±å“å°é¼ é¥®é£Ÿè¯±å¯¼çš„è‚¥èƒ– [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311153">GSE311153 æˆç†Ÿè„‚è‚ªç»†èƒä¸­èŠ³çƒƒå—ä½“çš„æ¿€æ´»ä¸å½±å“å°é¼ é¥®é£Ÿè¯±å¯¼çš„è‚¥èƒ– [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264412">GSE264412 3ä¾‹DIPGç—…ä¾‹çš„æ‰¹é‡RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314652">GSE314652 é¶å‘ mTORC2 ä¾èµ–æ€§ AKT/FOXO1/RNF125 ä¿¡å·é€šè·¯åˆ©ç”¨ c-MET æ¿€æ´»å’Œ Î²-catenin çªå˜è‚ç»†èƒç™Œçš„æ²»ç–—å¼±ç‚¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314476">GSE314476 å¤–æºæ€§å¤©å†¬é…°èƒºå¯¹ç»“ç›´è‚ è‚¿ç˜¤ç”Ÿé•¿ã€17Î²-é›ŒäºŒé†‡æ°´å¹³å’ŒèŠ³é¦™åŒ–é…¶çš„æ€§åˆ«ç‰¹å¼‚æ€§å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314025">GSE314025 å®‰æ ¼æ›¼ç»¼åˆå¾çŒªæ¨¡å‹é¢å¶çš®è´¨å•æ ¸RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314021">GSE314021 æœ‰ä¸åˆ†è£‚ç»†èƒä¸­è½¬å½•ç»„çš„å…¨å±€ç¨³å®šæ€§ [PALseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313978">GSE313978 è†³é£Ÿé«˜çº¤ç»´å’ŒN-æ°¨ç”²é…°è°·æ°¨é…¸é€šè¿‡è°ƒèŠ‚ä¹³é…¸æ†èŒã€è„‚è´¨ä»£è°¢ç‰©å’ŒPI3K-Aktä¿¡å·é€šè·¯æé«˜æ¯çŒªç¹æ®–æ€§èƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313951">GSE313951 ç¥–å…ˆç›¸å…³çš„IL-10ä¿¡å·ä¼ å¯¼å’Œå·¨å™¬ç»†èƒæ´»åŒ–è°ƒèŠ‚åŸºäºPEGçš„å¾®ç”Ÿç†ç³»ç»Ÿä¸­æˆçº¤ç»´ç»†èƒå¯¹æ°§åŒ–åº”æ¿€çš„ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313865">GSE313865ï¼šæ‰¬å­é²Ÿå•ç»†èƒå›¾è°±æ­ç¤ºæ´»åŒ–çŸ³é±¼ç±»çš„æ¼”åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313693">GSE313693 è„‘è†œç˜¤å•æ ¸RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295714">GSE295714 æœºæ¢°æ•æ„Ÿæ€§ TRPV4 ä¸ NF-ÎºB ä¹‹é—´çš„æ–°å‹ä¸²æ‰°æŠ‘åˆ¶è‚ºéƒ¨ç‚ç—‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289109">GSE289109 ç‚ç—‡è„‘ä¸­ç¥ç»å…ƒå‘ç”Ÿ IFNÎ³ é©±åŠ¨çš„æŒç»­è¡¨è§‚é—ä¼ æ”¹å˜å’Œçªè§¦é‡å¡‘ [snRNA-Seq]</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-23 21:37</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week522025/ rel=tag>Week522025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-12-23/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-23</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-25/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-25</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-08/>ç§‘ç ”æ—¥æŠ¥ 2026-01-08</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-07/>ç§‘ç ”æ—¥æŠ¥ 2026-01-07</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-06/>ç§‘ç ”æ—¥æŠ¥ 2026-01-06</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-05/>ç§‘ç ”æ—¥æŠ¥ 2026-01-05</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-04/>ç§‘ç ”æ—¥æŠ¥ 2026-01-04</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (71)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (71)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>